Testing effectiveness (Phase 2)UnknownNCT06487039
What this trial is testing
Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degeneration
Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
EyebioKorea, Inc. 50